Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 9/20 | 0.55 |
| ▸ | ADORA1 | P30542 | 7/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 6/20 | 0.55 |
| ▸ | ADORA2B | P29275 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5785842 | 0.89 | ADORA2A (0.54) | ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL5787999 | 0.85 | ADORA2A (0.57) | ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL5784479 | 0.82 | ADORA2A (0.49) | ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL9327254 | 0.76 | ADORA2A (0.81) | ADORA2AADORA1ADORA3ADORA2BALDH1A1 | |
| SCHEMBL6010026 | 0.76 | ADORA2A (0.45) | ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL5410869 | 0.75 | ADORA2A (0.62) | ADORA2AADORA1ADORA3ADORA2BALDH1A1 | |
| SCHEMBL6010465 | 0.74 | ADORA2A (0.37) | ADORA2AADORA1 | |
| SCHEMBL6009997 | 0.73 | ADORA2A (0.44) | ADORA2AADORA1ADORA3ADORA2B | |
| SCHEMBL5418880 | 0.73 | — | — | |
| SCHEMBL6009814 | 0.73 | ADORA2A (0.38) | ADORA2AADORA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1615930-A2 | TRIAZOLOTRIAZINES AND PYRAZOLOTRIAZINES USEFUL AS A2A ADENOSINE RECEPTOR ANTAGONISTS | Biogen Idec MA, Inc. (US) | 2006-01-18 | — | — | EP | claimed |
| WO-2004092170-A2 | TRIAZOLOTRIAZINES AND PYRAZOLOTRIAZINES USEFUL AS A2A ADENOSINE RECEPTOR ANTAGON ISTS | BIOGEN IDEC MA INC. (US) | 2004-10-28 | — | — | WO | claimed |